Skip to main content

Shattuck Labs, Inc.

STTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001680367

In the last 90 days, Shattuck Labs, Inc. insiders filed 0 open-market purchases and 1 sale; 100 institutions reported holding it in 13F filings for Q2 2026, worth $581.3M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Shattuck Labs, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of STTK: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders7561−14
Shares31.2M28.7M−2.50M (−8.0%)
Value$29.6M$22.7M−$6.98M (−23.5%)

New holders (11)

Institutions that held Shattuck Labs, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to STTK in Q2 2025
InstitutionSharesValue% of portfolio
Y-Intercept (Hong Kong) Ltd123,172$97.5K0.00%
Qube Research & Technologies Ltd55,380$43.9K0.00%
Jain Global LLC34,525$27.3K0.00%
Point72 Asia (Singapore) Pte. Ltd.28,908$22.9K0.00%
HSBC Holdings PLC16,122$12.9K0.00%
Cubist Systematic Strategies, LLC3,812$3.02K0.00%
Briaud Financial Planning, Inc2,227$1.00K0.00%
Point72 (DIFC) Ltd1,090$8630.00%
Raymond James Financial Inc250$1980.00%
Clearstead Advisors, LLC155$1230.00%
Simplex Trading, LLC1,156$00.00%

Sold out (25)

Institutions that held Shattuck Labs, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.